Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: A clinical and molecular analysis of 423 patients.

Although it did not reach statistical significance, perhaps because of the limited number of patients, we also observed a trend toward shorter survival in individuals with melanoma and head and neck tumors ( Fig. 2B,C ).

also in 111,027 other papers